State pharmacy boards overreach in regulating PBMs, compounders

01/23/2013 | Bloomberg BNA (subscription required)

State pharmacy boards, whose members include pharmacists, have an inherent conflict of interest in regulating and overseeing the thousands of pharmacies nationwide that combine, mix or alter prescription drugs, health care attorney William G. Schiffbauer writes. Pharmacy boards have further overreached their role of self-regulating pharmacists in claiming authority to regulate pharmacy benefit managers, with whom they are often in competition, Schiffbauer adds. State pharmacy boards' authority should be limited to regulating the behavior and competence of pharmacists, finding and disciplining problem pharmacists and handling conflicts of interest in the pharmacy profession, Schiffbauer writes.

View Full Article in:

Bloomberg BNA (subscription required)